Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Explore our Apr 2022 issue

Please add [email protected] to your Safe Senders list. If you have trouble viewing this message, click here to view it online.
ADVERTISEMENT
In this issue of The Lancet Diabetes & Endocrinology:
Vol. 10
Number 4 | Apr 2022
p 231​-​296 | e4​-​e7
My Account Subscribe Authors About
Twitter Podcast
FEATURES
Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis.
Read this Article
Cancer research from bench to bedside: cancer affects everyone and represents a tremendous burden for patients, families, and societies. The Lancet Group is committed to accelerating progress against cancer and would like to extend an opportunity to publish all types of high-quality studies, including original research.
Read this call for papers
Editorial
Ukraine: diabetes on the front line
Comment
From preeclampsia to thyroid dysfunction: a long and winding road
The actual burden of obesity—accounting for multimorbidity
Global thyroid estimates in 2020
Women in diabetes research: stepping towards equity
Creating diabetes guidelines for the individual not just the illness
Thank you to The Lancet Diabetes & Endocrinology clinical and statistical peer reviewers in 2021
Correspondence
Data processing in the DMagic cluster randomised controlled trial
Corrections
Correction to Lancet Diabetes Endocrinol 2020; 8: 594–605
Corrections to Lancet Diabetes Endocrinol 2022; 10: 120–28
Articles
Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis
Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study
Open Access
The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020
Review
Osteoporosis in men
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
View the entire Table of Contents online
CONTENT
Online First
Commissions
Series
MULTIMEDIA
Infographics
Podcasts
Videos
INFO & SERVICES
Lancet Alerts
Open Access
Publishing excellence
The best science for better lives
You are receiving this email because you subscribed to TheLancet.­com alerting service.
Update mailing preferences to choose which Lancet journals you receive alerts from. Follow this link to unsubscribe.
Privacy Policy
Copyright © 2022 Elsevier Limited except certain content provided by third parties. The Lancet is a trade mark of Elsevier Limited.
Subscription ID: 3a47a682-beef-4080-939e-07e34b064bd0 Webuser ID: 68907248 Results Event ID: 646f6324-1896-4b38-8e9b-5e041f17195e


This post first appeared on Clinical Trials News, please read the originial post: here

Share the post

Explore our Apr 2022 issue

×

Subscribe to Clinical Trials News

Get updates delivered right to your inbox!

Thank you for your subscription

×